China would approve its first coronavirus drug in December

China would have everything ready to launch the first drug to combat the coronavirus through the use of monoclonal antibodies capable of neutralizing the virus, state media reported on Tuesday.

The treatment is the result of a joint investigation Tsinghua University, Shenzhen People’s Hospital Number Three (southeast) and Brii Biosciences company, which is headquartered in both China and the United States.

“The human body produces a large amount of antibodies, but not all of them have antiviral efficacy. Our research aims to select the strongest so that they can be used in drug form to treat infected patients,” he explained Zhang Linqi, professor at the Tsinghua University School of Medicine, in dialogue with Global Times.

According to the data released so far, this type of drug would be used to treat mild or moderate cases of Covid-19.

The Brii Biosciences company announced in late August that the treatment demonstrated a reduction of up to 78 percent in hospitalizations and deaths due to coronavirus during a third phase of clinical trials carried out in the US, Brazil, South Africa, Mexico, Argentina and the Philippines.

Vaccination against the coronavirus in Nanchang, China. Photo Xinhua

So far, the experimental drug has been administered to more than 700 patients who contracted the disease during the recent and still active wave of outbreaks in the Asian country, attributed to the contagious Delta variant.

Likewise, Chinese companies and institutions are developing two other drugs to counteract the effects of the coronavirus.

The state pharmaceutical Sinopharm (responsible for two vaccines against Covid-19 that are used in several countries) is investigating a therapy based on the plasma of recovered patients and whose clinical trials will begin in a few weeks in the United Arab Emirates.

Meanwhile, the biotechnology company Kintor is working on a third formula that is also in the testing phase.

China accumulates since the beginning of the pandemic 98,337 infections -22 of them notified this Tuesday- and 4,636 fatalities by Covid-19, according to data released by the National Health Commission.

The Asian country for the moment rules out living with the virus and maintains a policy of “zero tolerance” with the virus that entails a strict border closure and the application of harsh containment measures and mobility restrictions every time outbreaks are detected in its territory.

In this context, more than 11,000 university students were quarantined on Monday due to a sudden increase in coronavirus cases in the city of Dalian, in Liaoning province.

By Editor

Leave a Reply